biote Corp. (BTMD) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-14

Key Insights

Director Andrew R. Heyer received 35,259 Deferred Settlement RSUs that vest upon grant but settle at separation from service, indicating equity compensation tied to long-term retention rather than immediate value realization.
Grant of 130,000 stock options at $2.20 exercise price with vesting on May 12, 2027 (or prior to 2027 Annual Meeting) demonstrates continued confidence in company leadership and aligns insider interests with future stock performance.
Total equity grants of approximately 165,259 securities (RSUs plus option shares) represent substantial compensation packages, but the deferred settlement structure and one-year vesting suggest measured confidence rather than aggressive near-term bullish positioning.
Filing was executed by attorney-in-fact rather than the director personally, which is routine but may indicate the director was unavailable at time of submission.

Want the newest filings?

This analysis covers the filing from 2026-05-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-03

Robert Charles Peterson, the Chief Financial Officer of biote Corp., acquired 107,169 stock options on 2026-04-01 at an exercise price of $1.43 per share.
The options will vest over 36 months, with 25% vesting on 2027-04-01 and the remaining shares vesting monthly thereafter.
This insider transaction suggests that the CFO is confident in the company's future prospects and is aligning his interests with those of shareholders.

Filed: 2026-04-03

Bret Christensen, the CEO of biote Corp. (BTMD), acquired a new stock option grant of 441,653 shares of Class A common stock, vesting over 36 months.
The exercise price of the new option grant is $1.43 per share, which appears to be at the current market price based on the information provided.
Insider buying of this magnitude by the CEO is generally seen as a positive signal, indicating his confidence in the company's future performance.

Other reports for biote Corp.

Quarterly Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.